BUSINESS BRIEFING / DRUGS
- Share via
Merck & Co. and Schering-Plough Corp. will pay $5.4 million to settle a multistate investigation into whether they delayed the release of test results casting doubt on the effectiveness of two blockbuster cholesterol drugs.
The firms settled with attorneys general from 35 states and the District of Columbia. The probe centered on allegations that they kept quiet the results from an unfavorable study. Merck and Schering-Plough will pay the costs of the investigation but don’t have to admit wrongdoing or liability.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
